Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sedative Effect and Safety of Remiazolam Combined With Low-dose Esketamine in Painless Bidirectional Endoscopy in Children

NCT05686863 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT05686863
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05686863 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sedative Effect and Safety of Remiazolam Combined With Low-dose Esketamine in Painless Bidirectional Endoscopy in Children
Lead sponsor
Tongji Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 18, 2023
Completion date
July 7, 2023
Enrollment
106 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug effect